Taruna Madhav Crawford, MD
Hand Surgery · Bourbonnais, ILNPI 1487865788
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Axogen at 33.5% of the total.
Across 46 payments — averaging $91.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$1K
- Sonex Health, Inc.$1K
- Acumed LLC$727
- Johnson & Johnson$478
- AbbVie$136
- Stryker$92
- plus $283 from 10 others
What the payments were for
- Travel & lodging$2,25454%
- Food & beverage$1,94846%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 3 | $1,407 |
| Sonex Health, Inc. | 10 | $1,078 |
| Acumed LLC | 1 | $727 |
| Johnson & Johnson(2 entities) | 8 | $478 |
| AbbVie | 7 | $136 |
| Stryker | 3 | $92 |
| Orthofix Medical, Inc. | 4 | $63 |
| Catalyst Orthoscience | 1 | $47 |
| Integra Lifesciences Corporation | 2 | $42 |
| Aroa Biosurgery Incorporated | 1 | $25 |
| Smith+Nephew | 1 | $24 |
| Bioventus LLC | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Vericel Corporation | 1 | $16 |
| DJO, LLC | 1 | $15 |
| Polynovo North America LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AxoGuard Nerve Protector$1,342
- AxoGuard Nerve Connector$1,342
- ULTRAGUIDECTR$737
- ULTRAGUIDETFR$737
- ACUMED$727
- Sx-One Microknife$158
- NA$110
- HAMMERLOCK$108
How this compares
$4,202 in reported general payments places this provider in the 65th percentile of 121 hand surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 28 | $396 |
| Methylprednisolone | 15 | $75 |
| Meloxicam | 28 | $62 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Bourbonnais
- Jeffrey VisotskyMorton Grove$1.1M
- Robert GraySkokie$422K
- Robert CoatsTinley Park$408K
- Randipsingh BindraMaywood$297K
- Jonathan TuetingAurora$190K
- Mark CohenChicago$78K
- Jeffrey StepanChicago$71K
- Leon BensonGlenview$62K
- Debdut BiswasWarrenville$56K
- Eric PerezChicago$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.